BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology. 2005;237:170-180. [PMID: 16126930 DOI: 10.1148/radiol.2371041444] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Chan VO, Das JP, Gerstenmaier JF, Geoghegan J, Gibney RG, Collins CD, Skehan SJ, Malone DE. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Ir J Med Sci 2012;181:499-509. [DOI: 10.1007/s11845-012-0805-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
2 Juchems MS, Wessling J. [Rational staging and follow-up of colorectal cancer : Do guidelines provide further help?]. Radiologe 2019;59:820-7. [PMID: 31455978 DOI: 10.1007/s00117-019-0578-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Carpenter S, Fong Y. Management of disappearing colorectal hepatic metastases. Adv Surg 2010;44:269-79. [PMID: 20919526 DOI: 10.1016/j.yasu.2010.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
4 Kouwenhoven S, Liefers G, van Erkel A. The pre-operative stratification of patients with colorectal liver metastases: Computed tomography arterial portography (CTAP) has no added value. European Journal of Surgical Oncology (EJSO) 2010;36:36-42. [DOI: 10.1016/j.ejso.2009.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Grassetto G, Fornasiero A, Bonciarelli G, Banti E, Rampin L, Marzola MC, Massaro A, Galeotti F, Del Favero G, Pasini F. Additional value of FDG-PET/CT in management of “solitary” liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Biol. 2010;12:139-144. [PMID: 19626378 DOI: 10.1007/s11307-009-0249-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
6 Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol. 2011;79:e1-e6. [PMID: 20392584 DOI: 10.1016/j.ejrad.2010.03.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
7 Liu PS, Francis IR. Hepatic Imaging for Metastatic Disease. The Cancer Journal 2010;16:93-102. [DOI: 10.1097/ppo.0b013e3181d7ea21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Chou CT, Chen RC, Chen WT, Lii JM. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging. Clin Radiol 2009;64:22-9. [PMID: 19070694 DOI: 10.1016/j.crad.2008.07.010] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Mantatzis M, Kakolyris S, Amarantidis K, Karayiannakis A, Prassopoulos P. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate? Eur Radiol 2009;19:1809-16. [PMID: 19238395 DOI: 10.1007/s00330-009-1327-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
10 Polat E, Bostanci EB, Aksoy E, Karaman K, Poyraz NY, Duman U, Gencturk ZB, Yol S. The impact of PET/CT on the management of hepatic and extra hepatic metastases from gastrointestinal cancers. Eur J Radiol 2015;84:1165-70. [PMID: 25814398 DOI: 10.1016/j.ejrad.2015.02.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Qu J, Han S, Zhang H, Liu H, Wang Z, Kamel IR, Berthold K, Dominik NM, Zhang J, Zhang S, Dong Y, Jiang L, Liu C, Li H. Arterial Phase with CAIPIRINHA-Dixon-TWIST (CDT)-Volume-Interpolated Breath-Hold Examination (VIBE) in Detecting Hepatic Metastases. Transl Oncol 2017;10:46-53. [PMID: 27940372 DOI: 10.1016/j.tranon.2016.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Reiter MJ, Hannemann NP, Schwope RB, Lisanti CJ, Learn PA. Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know. Abdom Imaging 2015;40:3029-42. [PMID: 26194812 DOI: 10.1007/s00261-015-0507-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Robinson PJ. The effects of cancer chemotherapy on liver imaging. Eur Radiol. 2009;19:1752-1762. [PMID: 19238392 DOI: 10.1007/s00330-009-1333-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
14 Robinson E, Babb J, Chandarana H, Macari M. Dual Source Dual Energy MDCT: Comparison of 80 kVp and Weighted Average 120 kVp Data for Conspicuity of Hypo-Vascular Liver Metastases. Investigative Radiology 2010;45:413-8. [DOI: 10.1097/rli.0b013e3181dfda78] [Cited by in Crossref: 87] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
15 Robitaille PL. Ultra High Field Magnetic Resonance Imaging: A Historical Perspective. Ultra High Field Magnetic Resonance Imaging. Boston: Springer US; 2006. pp. 1-17. [DOI: 10.1007/978-0-387-49648-1_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Lochan R, White SA, Manas DM. Liver resection for colorectal liver metastasis. Surg Oncol 2007;16:33-45. [PMID: 17544654 DOI: 10.1016/j.suronc.2007.04.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
17 Stang A, Keles H, Hentschke S, Seydewitz C, Keuchel M, Pohland C, Dahlke J, Weilert H, Wessling J, Malzfeldt E. Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone. Invest Radiol 2010;45:491-501. [PMID: 20458251 DOI: 10.1097/RLI.0b013e3181ddd3da] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
18 Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol. 2006;16:1337-1345. [PMID: 16453115 DOI: 10.1007/s00330-005-0140-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
19 Giangregorio F. Contrast-Enhanced Ultrasound (CEUS) for Echographic Detection of Hepato Cellular Carcinoma in Cirrhotic Patients Previously Treated with Multiple Techniques: Comparison of Conventional US, Spiral CT and 3-Dimensional CEUS with Navigator Technique (3DNav CEUS). Cancers (Basel) 2011;3:1763-76. [PMID: 24212781 DOI: 10.3390/cancers3021763] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Cohen MP, Herman P, Chojniak R, Poli MR, Barbosa PN, Bitencourt AG. Focused abdominal ultrasound in preoperative liver surgery staging: a prospective study. World J Surg Oncol 2013;11:138. [PMID: 23768101 DOI: 10.1186/1477-7819-11-138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Menu Y, Bessoud B, Rocher L, Lesavre A, Phan C, Rangheard A. Lésions hépatiques en cancérologie générale. Journal de Radiologie 2007;88:1091-103. [DOI: 10.1016/s0221-0363(07)89921-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Chandarana H, Taouli B. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am. 2010;18:451-464, x. [PMID: 21094449 DOI: 10.1016/j.mric.2010.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
23 Giangregorio F, Comparato G, Marinone MG, Di Stasi M, Sbolli G, Aragona G, Tansini P, Fornari F. Imaging detection of new HCCs in cirrhotic patients treated with different techniques: Comparison of conventional US, spiral CT, and 3-dimensional contrast-enhanced US with the Navigator technique (Nav 3D CEUS)(). J Ultrasound 2009;12:12-21. [PMID: 23397019 DOI: 10.1016/j.jus.2009.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
24 Sofue K, Tsurusaki M, Miyake M, Sakurada A, Arai Y, Sugimura K. Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients. Eur Radiol. 2010;20:2265-2273. [PMID: 20428875 DOI: 10.1007/s00330-010-1798-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
25 Arciero CA, Sigurdson ER. Diagnosis and treatment of metastatic disease to the liver. Semin Oncol 2008;35:147-59. [PMID: 18396200 DOI: 10.1053/j.seminoncol.2007.12.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
26 Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging. 2010;35:511-521. [PMID: 19562412 DOI: 10.1007/s00261-009-9555-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
27 Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med. 2010;51:692-699. [PMID: 20395324 DOI: 10.2967/jnumed.109.068510] [Cited by in Crossref: 105] [Cited by in F6Publishing: 86] [Article Influence: 8.8] [Reference Citation Analysis]
28 Layer G, Delorme S. [Radiological diagnosis of hepatic tumors. Part II: Identification and differential diagnosis]. Radiologe 2007;47:919-31; quiz 932-3. [PMID: 17898982 DOI: 10.1007/s00117-007-1564-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Mainenti PP, Romano F, Pizzuti L, Segreto S, Storto G, Mannelli L, Imbriaco M, Camera L, Maurea S. Non-invasive diagnostic imaging of colorectal liver metastases. World J Radiol 2015; 7(7): 157-169 [PMID: 26217455 DOI: 10.4329/wjr.v7.i7.157] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
30 Ward J. Use of contrast agents for liver MRI. Radiography 2007;13:e54-72. [DOI: 10.1016/j.radi.2006.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
31 Smith TJ, Korngold E, Orloff SL. Preoperative Imaging in Colorectal Liver Metastases: Current Practices. Curr Surg Rep 2014;2. [DOI: 10.1007/s40137-013-0039-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Salem S, Houseni M, Zidan L, Kandil A. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion. Nucl Med Biol 2015;42:637-42. [PMID: 25907467 DOI: 10.1016/j.nucmedbio.2015.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Hoeffel C, Mulé S, Romaniuk B, Ladam-Marcus V, Bouché O, Marcus C. Advances in radiological imaging of gastrointestinal tumors. Crit Rev Oncol Hematol. 2009;69:153-167. [PMID: 18674926 DOI: 10.1016/j.critrevonc.2008.06.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
34 van Kessel CS, Buckens CF, van den Bosch MA, van Leeuwen MS, van Hillegersberg R, Verkooijen HM. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19:2805-2813. [PMID: 22396005 DOI: 10.1245/s10434-012-2300-z] [Cited by in Crossref: 109] [Cited by in F6Publishing: 82] [Article Influence: 10.9] [Reference Citation Analysis]
35 Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M. Magnetic Resonance Imaging of Liver Metastasis. Semin Ultrasound CT MR. 2016;37:533-548. [PMID: 27986172 DOI: 10.1053/j.sult.2016.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
36 Motosugi U, Ichikawa T, Nakajima H, Sou H, Sano M, Sano K, Araki T, Iino H, Fujii H, Nakazawa T. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age? J Comput Assist Tomogr 2009;33:266-72. [PMID: 19346857 DOI: 10.1097/RCT.0b013e31817f5c82] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
37 Ariff B, Lloyd CR, Khan S, Shariff M, Thillainayagam AV, Bansi DS, Khan SA, Taylor-Robinson SD, Lim AK. Imaging of liver cancer. World J Gastroenterol 2009; 15(11): 1289-1300 [PMID: 19294758 DOI: 10.3748/wjg.15.1289] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
38 Rappeport ED, Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging. 2007;32:624-634. [PMID: 17710359 DOI: 10.1007/s00261-007-9297-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
39 Kim H, Yu JS, Cho ES, Chung JJ, Kim JH, Kim DJ, Ahn JH, Kim KW. Diffusion-weighted imaging versus superparamagnetic iron oxide (SPIO)-enhanced MRI: exclusive and combined values in the assessment of hepatic metastases. Magn Reson Imaging 2012;30:554-61. [PMID: 22316590 DOI: 10.1016/j.mri.2011.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Hata S, Imamura H, Aoki T, Hashimoto T, Akahane M, Hasegawa K, Bekku Y, Sugawara Y, Makuuchi M, Kokudo N. Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma. World J Surg 2011;35:2779-87. [PMID: 21959929 DOI: 10.1007/s00268-011-1264-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
41 Biasco G, Derenzini E, Grazi G, Ercolani G, Ravaioli M, Pantaleo M, Brandi G. Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties. Cancer Treatment Reviews 2006;32:214-28. [DOI: 10.1016/j.ctrv.2005.12.011] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 4.4] [Reference Citation Analysis]
42 Klippenstein DL, Lamonica DM. Preoperative imaging for metastasectomy. Surg Oncol Clin N Am 2007;16:471-92, vii. [PMID: 17606189 DOI: 10.1016/j.soc.2007.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
43 Cantisani V, Grazhdani H, Fioravanti C, Rosignuolo M, Calliada F, Messineo D, Bernieri MG, Redler A, Catalano C, D’Ambrosio F. Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance. World J Gastroenterol 2014; 20(29): 9998-10007 [PMID: 25110428 DOI: 10.3748/wjg.v20.i29.9998] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
44 Juchems MS, Aschoff AJ. [Current imaging for rectal cancer]. Chirurg 2009;80:274-80. [PMID: 19280082 DOI: 10.1007/s00104-008-1619-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Galea N, Cantisani V, Taouli B. Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging 2013;37:1260-76. [PMID: 23712841 DOI: 10.1002/jmri.23947] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
46 Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006;6:33-42. [PMID: 16766267 DOI: 10.1102/1470-7330.2006.0007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
47 Cresswell AB, Welsh FK, Rees M. A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford). 2009;11:533-540. [PMID: 20495704 DOI: 10.1111/j.1477-2574.2009.00081.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
48 Parlak C, Topkan E, Sonmez S, Onal C, Reyhan M. CT- versus coregistered FDG-PET/CT-based radiation therapy plans for conformal radiotherapy in colorectal liver metastases: a dosimetric comparison. Jpn J Radiol 2012;30:628-34. [DOI: 10.1007/s11604-012-0101-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Bartolotta TV, Taibbi A, Midiri M, Lagalla R. Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 2009;34:193-209. [DOI: 10.1007/s00261-008-9378-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
50 Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg. 2014;4:181-189. [PMID: 24914419 DOI: 10.3978/j.issn.2223-4292.2014.01.02] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
51 Angelsen JH, Viste A, Løes IM, Eide GE, Hoem D, Sorbye H, Horn A. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. World J Surg Oncol 2015;13:328. [PMID: 26631156 DOI: 10.1186/s12957-015-0738-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
52 Soloff EV, Zaheer A, Meier J, Zins M, Tamm EP. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease. Abdom Radiol 2018;43:301-13. [DOI: 10.1007/s00261-017-1410-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
53 Lauenstein TC, Salman K, Morreira R, Heffron T, Spivey JR, Martinez E, Sharma P, Martin DR. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. AJR Am J Roentgenol. 2007;189:663-670. [PMID: 17715115 DOI: 10.2214/AJR.07.2171] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
54 Schima W, Koh D, Baron R. Focal Liver Lesions. In: Hodler J, Kubik-huch RA, von Schulthess GK, editors. Diseases of the Abdomen and Pelvis 2018-2021. Cham: Springer International Publishing; 2018. pp. 173-96. [DOI: 10.1007/978-3-319-75019-4_17] [Reference Citation Analysis]
55 Calistri L, Castellani A, Matteuzzi B, Mazzoni E, Pradella S, Colagrande S. Focal Liver Lesions Classification and Characterization: What Value Do DWI and ADC Have? J Comput Assist Tomogr. 2016;40:701-708. [PMID: 27454786 DOI: 10.1097/rct.0000000000000458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
56 Layer G, Bohrer M. [Diagnostic radiology of liver tumors. Part 1: General disease aspects and radiological procedures]. Radiologe 2007;47:819-29; quiz 830-1. [PMID: 17786401 DOI: 10.1007/s00117-007-1553-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Shin NY, Kim MJ, Lim JS, Park MS, Chung YE, Choi JY, Kim KW, Park YN. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol. 2012;22:864-871. [PMID: 22108766 DOI: 10.1007/s00330-011-2333-x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
58 Xu LH, Cai SJ, Cai GX, Peng WJ. Imaging diagnosis of colorectal liver metastases. World J Gastroenterol 2011; 17(42): 4654-4659 [PMID: 22180707 DOI: 10.3748/wjg.v17.i42.4654] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
59 Choi J, Choi J, Kim M, Lim JS, Park MS, Kim JH, Chung YE. Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 2010;31:571-8. [DOI: 10.1002/jmri.22076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
60 Koh DM, Brown G, Riddell AM, Scurr E, Collins DJ, Allen SD, Chau I, Cunningham D, deSouza NM, Leach MO. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol. 2008;18:903-910. [PMID: 18193234 DOI: 10.1007/s00330-007-0847-z] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 8.1] [Reference Citation Analysis]
61 Li Destri G, Di Benedetto F, Torrisi B, Portale TR, Mosca F, Vecchio R, Di Cataldo A, Puleo S. Metachronous liver metastases and resectability: Fong's score and laparoscopic evaluation. HPB (Oxford) 2008;10:13-7. [PMID: 18773094 DOI: 10.1080/13651820701851384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
62 Young AL, Wilson D, Ward J, Biglands J, Guthrie JA, Prasad KR, Toogood GJ, Robinson PJ, Lodge JP. Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study. HPB (Oxford) 2012;14:194-200. [PMID: 22321038 DOI: 10.1111/j.1477-2574.2011.00426.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
63 Hekimoglu K, Ustundag Y, Dusak A, Kalaycioglu B, Besir H, Engin H, Erdem O. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging. Eur J Radiol 2011;77:468-72. [PMID: 19781882 DOI: 10.1016/j.ejrad.2009.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
64 Kang SI, Kim D, Cho JY, Park J, Lee KH, Son IT, Oh H, Kang S. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer? Diseases of the Colon & Rectum 2017;60:936-44. [DOI: 10.1097/dcr.0000000000000914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
65 Low RN. Abdominal MRI advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8:525-535. [PMID: 17540304 DOI: 10.1016/S1470-2045(07)70170-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
66 Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP, Toogood GJ. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246:806-814. [PMID: 17968173 DOI: 10.1097/sla.0b013e318142d964] [Cited by in Crossref: 144] [Cited by in F6Publishing: 55] [Article Influence: 9.6] [Reference Citation Analysis]
67 Mokdad A, Choti MA, Yopp AC. Conversion Chemotherapy for Unresectable Colorectal Liver Metastases: Are We Making a Difference? Curr Colorectal Cancer Rep 2015;11:160-7. [DOI: 10.1007/s11888-015-0271-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Chung WS, Kim MJ, Chung YE, Kim YE, Park MS, Choi JY, Kim KW. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. J Magn Reson Imaging. 2011;34:345-353. [PMID: 21702068 DOI: 10.1002/jmri.22671] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
69 Anton N, Parlog A, Bou About G, Attia MF, Wattenhofer-Donzé M, Jacobs H, Goncalves I, Robinet E, Sorg T, Vandamme TF. Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions. Sci Rep 2017;7:13935. [PMID: 29066853 DOI: 10.1038/s41598-017-14270-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
70 Tamandl D, Herberger B, Gruenberger B, Schoppmann SF, Puhalla H, Schindl M, Schima W, Jakesz R, Gruenberger T. Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery 2008;143:648-57. [DOI: 10.1016/j.surg.2007.11.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
71 Koelblinger C, Ba-Ssalamah A, Goetzinger P, Puchner S, Weber M, Sahora K, Scharitzer M, Plank C, Schima W. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology. 2011;259:757-766. [PMID: 21436084 DOI: 10.1148/radiol.11101189] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
72 Albrecht MH, Wichmann JL, Müller C, Schreckenbach T, Sakthibalan S, Hammerstingl R, Bechstein WO, Zangos S, Ackermann H, Vogl TJ. Assessment of colorectal liver metastases using MRI and CT: impact of observer experience on diagnostic performance and inter-observer reproducibility with histopathological correlation. Eur J Radiol 2014;83:1752-8. [PMID: 25082480 DOI: 10.1016/j.ejrad.2014.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
73 Kim HJ, Lee SS, Byun JH, Kim JC, Yu CS, Park SH, Kim AY, Ha HK. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology. 2015;274:712-722. [PMID: 25286324 DOI: 10.1148/radiol.14140390] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
74 Bellomi M, Travaini LL. Imaging as a surveillance tool in rectal cancer. Expert Rev Med Devices 2010;7:99-112. [PMID: 20021242 DOI: 10.1586/erd.09.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
75 Shah AJ, Phull J, Finch-jones MD. Clinical Risk Score Can be Used to Select Patients for Staging Laparoscopy and Laparoscopic Ultrasound for Colorectal Liver Metastases. World J Surg 2010;34:2141-5. [DOI: 10.1007/s00268-010-0630-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006;24:3939-45. [PMID: 16921046 DOI: 10.1200/JCO.2006.05.8727] [Cited by in Crossref: 409] [Cited by in F6Publishing: 116] [Article Influence: 25.6] [Reference Citation Analysis]
77 Amraee A, Khoei S, Bahreyni-toossi MT, Azimian H, Ansari F, Fallahi F, Robatmili N, Teshnizi SH, Darvish L. Evaluation of ultra-small iron oxide nanoparticles as T1-weighted MRI contrast in cancerous tissues: a meta-analysis. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00491-y] [Reference Citation Analysis]
78 Heinemann V, Rummeny EJ, Knoefel WT, Tannapfel A, Reinacher-schick A. Management von Lebermetastasen. Oncol Res Treat 2007;30:5-12. [DOI: 10.1159/000106452] [Reference Citation Analysis]
79 Angliviel B, Benoist S, Penna C, El Hajjam M, Chagnon S, Julié C, Beauchet A, Rougier P, Nordlinger B. Impact of Chemotherapy on the Accuracy of Computed Tomography Scan for the Evaluation of Colorectal Liver Metastases. Ann Surg Oncol 2009;16:1247-53. [DOI: 10.1245/s10434-009-0385-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
80 Bacigalupo L, Aufort S, Eberlé MC, Assenat E, Ychou M, Gallix B. Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT. Radiol Med 2010;115:1087-100. [PMID: 20574703 DOI: 10.1007/s11547-010-0560-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
81 Chami L, Lassau N, Malka D, Ducreux M, Bidault S, Roche A, Elias D. Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. AJR Am J Roentgenol. 2008;190:683-690. [PMID: 18287439 DOI: 10.2214/AJR.07.2295] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
82 Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254:47-66. [PMID: 20032142 DOI: 10.1148/radiol.09090021] [Cited by in Crossref: 575] [Cited by in F6Publishing: 485] [Article Influence: 47.9] [Reference Citation Analysis]
83 Sahani DV, Bajwa MA, Andrabi Y, Bajpai S, Cusack JC. Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma. Ann Surg. 2014;259:861-872. [PMID: 24509207 DOI: 10.1097/sla.0000000000000525] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 5.1] [Reference Citation Analysis]
84 Engelen SM, Beets GL, Beets-tan RG. Role of Preoperative Local and Distant Staging in Rectal Cancer. Oncol Res Treat 2007;30:141-5. [DOI: 10.1159/000099026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
85 Nagayama Y, Iyama A, Oda S, Taguchi N, Nakaura T, Utsunomiya D, Kikuchi Y, Yamashita Y. Dual-layer dual-energy computed tomography for the assessment of hypovascular hepatic metastases: impact of closing k-edge on image quality and lesion detectability. Eur Radiol 2019;29:2837-47. [PMID: 30377793 DOI: 10.1007/s00330-018-5789-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
86 Rojas Llimpe FL, Di Fabio F, Ercolani G, Giampalma E, Cappelli A, Serra C, Castellucci P, D'Errico A, Golfieri R, Pinna AD, Pinto C. Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study. Br J Cancer. 2014;111:667-673. [PMID: 24983362 DOI: 10.1038/bjc.2014.351] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
87 Park JM, Kim IY, Kim SW, Lee SM, Kim HG, Kim SY, Shin HC. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location. Ann Nucl Med 2013;27:217-24. [PMID: 23242953 DOI: 10.1007/s12149-012-0677-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
88 Floriani I, Torri V, Rulli E, Garavaglia D, Compagnoni A, Salvolini L, Giovagnoni A. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2010;31:19-31. [PMID: 20027569 DOI: 10.1002/jmri.22010] [Cited by in Crossref: 168] [Cited by in F6Publishing: 126] [Article Influence: 14.0] [Reference Citation Analysis]
89 Meijerink MR, van Waesberghe JH, Golding RP, van der Weide L, van den Tol P, Meijer S, van Kuijk C. Subtraction-multiphase-CT unbeneficial for early detection of colorectal liver metastases. Eur J Radiol 2010;74:e132-7. [PMID: 19515521 DOI: 10.1016/j.ejrad.2009.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
90 Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Kitamura T, Faima Z, Fukushima K, Araki T, Iino H, Mori Y, Fujii H. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging. J Magn Reson Imaging 2010;32:1132-40. [DOI: 10.1002/jmri.22360] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
91 Artigas V, Marín-Hargreaves G, Marcuello E, Pey A, González JA, Rodríguez M, Moral A, Monill JM, Sancho J, Pericay C. [Surgical resection of liver metastases from colorectal carcinoma. Experience in Sant Pau Hospital]. Cir Esp. 2007;81:339-344. [PMID: 17553407 DOI: 10.1016/S0009-739X(07)71334-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
92 Ward J, Guthrie JA, Sheridan MB, Boyes S, Smith JT, Wilson D, Wyatt JI, Treanor D, Robinson PJ. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol. 2008;26:4304-4310. [PMID: 18779617 DOI: 10.1200/jco.2008.16.1893] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
93 Freimuth J, Gassler N, Moro N, Günther RW, Trautwein C, Liedtke C, Krombach GA. Application of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma. Mol Cancer 2010;9:94. [PMID: 20429921 DOI: 10.1186/1476-4598-9-94] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
94 Smith JT, Ward J, Guthrie JA, Sheridan MB, Boyes S, Wilson D, Wyatt JI, Treanor D, Robinson PJ. Detection of colorectal metastases in patients being treated with chemotherapy utilising SPIO-MRI: a radiological–pathological study. Magnetic Resonance Imaging 2012;30:1446-53. [DOI: 10.1016/j.mri.2012.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
95 Mann CD, Neal CP, Metcalfe MS, Pattenden CJ, Dennison AR, Berry DP. Clinical Risk Score predicts yield of staging laparoscopy in patients with colorectal liver metastases. British Journal of Surgery 2007;94:855-9. [DOI: 10.1002/bjs.5730] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
96 Schreiter NF, Nogami M, Steffen I, Pape U, Hamm B, Brenner W, Röttgen R. Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours. Eur Radiol 2012;22:458-67. [DOI: 10.1007/s00330-011-2266-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
97 O'Rourke TR, Welsh FK, Tekkis PP, Lyle N, Mustajab A, John TG, Peppercorn D, Rees M. Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection. Eur J Surg Oncol. 2009;35:1085-1091. [PMID: 19246171 DOI: 10.1016/j.ejso.2009.01.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
98 Tanimoto A. Use of SPIOs for Clinical Liver Imaging. In: Bulte JW, Modo MM, editors. Nanoparticles in Biomedical Imaging. New York: Springer; 2008. pp. 41-61. [DOI: 10.1007/978-0-387-72027-2_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, Cunningham D, Cook GJ. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging. 2008;35:1323-1329. [PMID: 18347794 DOI: 10.1007/s00259-008-0743-z] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 6.6] [Reference Citation Analysis]
100 Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T. Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011;34:326-35. [DOI: 10.1002/jmri.22613] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 9.3] [Reference Citation Analysis]
101 Scharitzer M, Ba-Ssalamah A, Ringl H, Kölblinger C, Grünberger T, Weber M, Schima W. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol. 2013;23:2187-2196. [PMID: 23519439 DOI: 10.1007/s00330-013-2824-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]